Repligen (RGEN) Reports Q4 Loss of $0.09, Misses by 3c
Repligen Corporation (Nasdaq: RGEN) reports Q4 loss of $0.09, 3 cents lower than the analyst estimate of ($0.06). Revenue for the quarter was $4.59 million, versus the consensus of $5 million.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
